This review article examines the existing research on how cannabinoids (both naturally produced within the body - endocannabinoids - and those from cannabis like THC) affect female sexual function. The authors conducted a literature search spanning 1970-2019, analyzing both animal and human studies. Animal studies, primarily using rats, suggest a dose-dependent effect, where low doses can enhance sexual receptivity, while higher doses appear to inhibit it. Human studies are largely based on self-reported data from questionnaires, but similarly indicate a potential for improved sexual desire and function with moderate use, with higher doses potentially being detrimental. The research highlights the complex interaction between the endocannabinoid system, hormones, and neurotransmitters involved in sexual response, and calls for more well-controlled studies given the increasing legalization of cannabis. The findings suggest that cannabinoids do impact female sexual function, but the nature of this impact (positive or negative) depends heavily on dosage, species, and other factors.
The DEA is promoting a contest run by Johnny’s Ambassadors, recruiting students to create videos warning about marijuana use for ‘Anti-420 Day’ and ‘flood’ Instagram with them. Students can earn Amazon gift cards for their submissions.
Two scientists, Dr. Miyabe Shields and Dr. Riley Kirk, are leveraging TikTok and Instagram to educate the public on cannabis pharmacology, gathering data from thousands of respondents on their experiences with cannabis.
Larvicidal Activity of Hemp Extracts and Cannabidiol against the Yellow Fever Mosquito Aedes aegyptiThe study examines the larvicidal activity of hemp leaf extracts and cannabidiol against pyrethroid-susceptible and pyrethroid-resistant strains of the yellow fever mosquito Aedes aegypti, identifying cannabidiol as the primary active ingredient.
Newly released recordings from President Richard Nixon’s Oval Office capture his views on marijuana, Black Power and the Vietnam War.
- DEA to move cannabis to Schedule III, recognizing its medical use and low potential for abuse.
- No change in federal illegality of marijuana products sold within state programs or interstate commerce.
- DOJ may reissue enforcement memo to not enforce federal law against compliant state-legal marijuana businesses.
- DEA's final rule based on HHS analysis, comments, and administrative hearing record.
- Effective 30 days after publication in Federal Register, with court order potentially delaying it.
- No change in federal illegality of marijuana products sold within state programs or interstate commerce.
- DOJ may reissue enforcement memo to not enforce federal law against compliant state-legal marijuana businesses.
- DEA's final rule based on HHS analysis, comments, and administrative hearing record.
- Effective 30 days after publication in Federal Register, with court order potentially delaying it.
